A New Nonhormonal Contraceptive Choice: The Vaginal pH Modulator

Virtual | Apr 28, 2021

About the Course

The high rate of unintended pregnancy in the United States suggests an unmet need for effective, patient-friendly birth control methods. The FDA has recently approved a nonhormonal, coitally dependent, user-controlled contraceptive that may help fill this gap.

In this activity, Patty Cason, RN, MS, FNP-C, David L. Eisenberg, MD, PhD, FACOG, and David J. Portman, MD, will discuss the role of vaginal pH modulators in contraception and how the current contraceptive trial design has contributed to the “creeping Pearl Index.”

Learning Objectives

After participating in this educational activity, learners should be better able to: 

  • Explain the advantages and drawbacks of vaginal pH modulation contraception
  • Identify strategies to overcome common misperceptions regarding gel-based contraceptives that may detract from greater consideration of vaginal pH modulators
  • Discuss the scientific data underlying the increasing pregnancy rate demonstrated in contemporary clinical trials on contraception use

Accreditation and Credit Designation Statement 

Global Learning Collaborative is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Global Learning Collaborative designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Omnia Education

Omnia Education logo